Switch to:
More From Other Websites
Covidien Announces Dividend Increase Sep 17 2014
4:00 pm Covidien increases quarterly dividend by 13% to $0.36 per share from $0.32 per share Sep 17 2014
Covidien's Two Neurovascular Trial Enrolments on Track Sep 16 2014
Covidien Announces Start of Enrollment in Two Neurovascular Clinical Trials Sep 15 2014
Covidien Announces Start of Enrollment in Two Neurovascular Clinical Trials Sep 15 2014
Paulson, Mindich and Soros Bought Covidien; Should You? Sep 11 2014
[video] Inversion crackdown all talk, no action? Sep 08 2014
The Zacks Analyst Blog Highlights: EGShares India Small Cap ETF, VanEck India Small Cap Index ETF,... Sep 08 2014
With Actively Managed Funds, Be Wary Of Expense Ratios Sep 04 2014
Paulson & Co. establishes a new position in Covidien in Q2 2014 Sep 04 2014
The Zacks Analyst Blog Highlights: Medtronic, Covidien, Bacterin International Holdings, Inogen and... Sep 03 2014
Public Pension Funds Stay Mum on Corporate Expats Sep 01 2014
Solution Designed Specifically for Med/Surg Floors Addresses Unmet Patient Surveillance Needs,... Sep 01 2014
Covidien Acquires Venous Disease Cure Developer Aug 29 2014
Covidien Acquires Venous Disease Treatment Developer Sapheon, Inc. Aug 28 2014
Mallinckrodt Nears Buy Point As Sales, Earnings Rise Aug 27 2014
Zacks Industry Outlook Highlights: Zimmer Holdings, Medtronic, Covidien, Stryker and Smith & Nephew Aug 27 2014
Covidien Investor Sues to Block Planned Sale to Medtronic Aug 26 2014
Covidien Acquires Reverse Medical, Shares Decline Aug 26 2014
Announcement under Irish Takeover Rules Relevant Securities in Issue – August 26, 2014 Aug 26 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK